Rodney J Hicks
Overview
Explore the profile of Rodney J Hicks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
458
Citations
11816
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Ingbritsen J, Callahan J, Morgan H, Munro M, Ware R, Hicks R
Cancer Imaging
. 2025 Jan;
25(1):7.
PMID: 39881380
True total-body and extended axial field-of-view (AFOV) PET/CT with 1m or more of body coverage are now commercially available and dramatically increase system sensitivity over conventional AFOV PET/CT. The Siemens...
3.
Thomas S, Callahan J, Conway P, Moon D, Morgan H, Ingbritsen J, et al.
Eur Urol Open Sci
. 2024 Dec;
71:49-56.
PMID: 39720335
Background And Objective: Although prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) has impacted the investigation and management of biochemical recurrence (BCR) of prostate cancer, negative scans are common...
4.
Glaudemans A, Lammertsma A, Cherry S, Erba P, Rominger A, Dierckx R, et al.
Eur J Nucl Med Mol Imaging
. 2024 Dec;
52(3):791-795.
PMID: 39661126
No abstract available.
5.
Prasad V, Koumarianou A, Denecke T, Sundin A, Deroose C, Pavel M, et al.
J Neuroendocrinol
. 2024 Dec;
37(2):e13479.
PMID: 39653582
Assessing the response to systemic therapy in neuroendocrine tumors (NET) is challenging since morphological imaging response is often delayed and not necessarily reflective of clinical benefit. Peptide receptor radionuclide therapy...
6.
Boehm E, Hung T, Akhurst T, Alipour R, Chiang C, Hicks R, et al.
Endocr Oncol
. 2024 Dec;
4(1):e240013.
PMID: 39649117
Background: Metastatic gastroenteropancreatic neuroendocrine neoplasms (GEPNEN) can cause ectopic Cushing's syndrome (ECS). ECS is highly morbid and medical therapy is complex and can be ineffective. Patients unsuitable for bilateral adrenalectomy...
7.
Noor A, McGowan E, Van Zuylekom J, Cullinane C, Roselt P, Hicks R, et al.
EJNMMI Radiopharm Chem
. 2024 Nov;
9(1):80.
PMID: 39589414
Background: Carbonic Anhydrase IX (CAIX) is a zinc metalloenzyme that is over-expressed in many cancers making it a valid target for targeted diagnostic imaging with Positron Emission Tomography (PET). The...
8.
Taieb D, Deandreis D, Hicks R
J Nucl Med
. 2024 Sep;
65(11):1685-1688.
PMID: 39299784
No abstract available.
9.
Hicks R, Ware R, Callahan J
Semin Nucl Med
. 2024 Sep;
55(1):11-20.
PMID: 39289090
PET/CT devices with an axial field-of-view (FOV) of 1 m allow simultaneous imaging from the head to the upper thighs, the typical axial extent of many "whole-body" oncological studies acquired...
10.
Sivakumaran T, Cardin A, Callahan J, Wong H, Tothill R, Hicks R, et al.
J Nucl Med
. 2024 Sep;
65(10):1557-1563.
PMID: 39237349
Cancer of unknown primary (CUP) represents a heterogeneous group of metastatic tumors for which standardized diagnostic work-up fails to identify the primary site. We aimed to describe the Peter MacCallum...